| # | Drug | Count |
|---|---|---|
| 0 | CELECOXIB | 3 |
| 1 | TERIPARATIDE | 3 |
| 2 | ATENOLOL | 2 |
| 3 | CARBAMAZEPINE | 2 |
| 4 | CARBOPLATIN | 2 |
| 5 | DOXAZOSIN | 2 |
| 6 | DOXAZOSIN MESYLATE | 2 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 2 |
| 8 | FUROSEMIDE | 2 |
| 9 | NAPROXEN SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SORBITOL | 1 | 0.0017 |
| 1 | PAMIDRONATE DISODIUM | 1 | 0.0003 |
| 2 | CHLORAMBUCIL | 1 | 0.0003 |
| 3 | BENAZEPRIL HYDROCHLORIDE | 1 | 0.0001 |
| 4 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 5 | MICONAZOLE NITRATE | 1 | 0.0001 |
| 6 | AGALSIDASE BETA | 1 | 0.0001 |
| 7 | EPOETIN ALFA | 1 | 0.0001 |
| 8 | NAPROXEN SODIUM 220MG | 1 | 0.0001 |
| 9 | DOXAZOSIN MESYLATE | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 1 | Loop Diuretic [EPC] | 3 |
| 2 | Parathyroid Hormone Analog [EPC] | 3 |
| 3 | beta-Adrenergic Blocker [EPC] | 3 |
| 4 | Alkylating Drug [EPC] | 2 |
| 5 | Benzodiazepine [EPC] | 2 |
| 6 | Corticosteroid [EPC] | 2 |
| 7 | Mood Stabilizer [EPC] | 2 |
| 8 | Platinum-based Drug [EPC] | 2 |
| 9 | Sulfonylurea [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Parathyroid Hormone Analog [EPC] | 3 | 0.0000 |
| 2 | Muscle Relaxant [EPC] | 1 | 0.0000 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Sulfonylurea [EPC] | 2 | 0.0000 |
| 5 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 7 | beta-Adrenergic Blocker [EPC] | 3 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 9 | Mood Stabilizer [EPC] | 2 | 0.0000 |